These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7638213)

  • 1. Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease.
    Walzem RL; Watkins S; Frankel EN; Hansen RJ; German JB
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7460-4. PubMed ID: 7638213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
    N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.
    Vázquez M; Merlos M; Adzet T; Laguna JC
    Br J Pharmacol; 1996 Mar; 117(6):1155-62. PubMed ID: 8882610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).
    Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G
    J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression.
    Moriel P; Okawabata FS; Abdalla DS
    IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
    Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
    Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo lipolysis of plasma triglycerides increases the resistance to oxidative modification of low-density lipoproteins.
    Skoglund-Andersson C; Karpe F; Hellénius ML; Regnström J; Hamsten A; Tornvall P
    Eur J Clin Invest; 2003 Jan; 33(1):51-7. PubMed ID: 12492452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.
    Hua X; Su J; Svenungsson E; Hurt-Camejo E; Jensen-Urstad K; Angelin B; Båvenholm P; Frostegård J
    Scand J Rheumatol; 2009; 38(3):184-9. PubMed ID: 19165647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of monounsaturated and polyunsaturated fatty acids on the development of cardiovascular disease].
    Aguilera CM; Ramírez-Tortosa MC; Mesa MD; Gil A
    Nutr Hosp; 2001; 16(3):78-91. PubMed ID: 11475681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein.
    Jürgens G; Ashy A; Esterbauer H
    Biochem J; 1990 Jan; 265(2):605-8. PubMed ID: 1689148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased oxidizability of low-density lipoproteins in hypothyroidism.
    Diekman T; Demacker PN; Kastelein JJ; Stalenhoef AF; Wiersinga WM
    J Clin Endocrinol Metab; 1998 May; 83(5):1752-5. PubMed ID: 9589687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients.
    Jain SK; McVie R; Jaramillo JJ; Chen Y
    Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
    Tertov VV; Kaplun VV; Orekhov AN
    Mol Cell Biochem; 1998 Jun; 183(1-2):141-6. PubMed ID: 9655188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.